MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · IEX Real-Time Price · USD
4.100
-0.200 (-4.65%)
At close: Jul 2, 2024, 4:00 PM
4.120
+0.020 (0.49%)
After-hours: Jul 2, 2024, 7:43 PM EDT
MacroGenics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for MacroGenics stock have an average target of 12.44, with a low estimate of 4.00 and a high estimate of 25. The average target predicts an increase of 203.41% from the current stock price of 4.10.
Analyst Consensus: Buy
* Price targets were last updated on May 24, 2024.
Analyst Ratings
The average analyst rating for MacroGenics stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 5 | 6 | 4 | 4 |
| Buy | 1 | 2 | 3 | 3 | 2 | 2 |
| Hold | 0 | 1 | 1 | 1 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 9 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $24 → $9 | Strong Buy | Maintains | $24 → $9 | +119.51% | May 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $16 → $4 | Hold | Maintains | $16 → $4 | -2.44% | May 13, 2024 |
| Barclays | Barclays | Buy Maintains $25 → $14 | Buy | Maintains | $25 → $14 | +241.46% | May 10, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $22 → $16 | Buy | Maintains | $22 → $16 | +290.24% | May 10, 2024 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $24 → $8 | Buy → Hold | Downgrades | $24 → $8 | +95.12% | May 10, 2024 |
Financial Forecast
Revenue This Year
67.40M
from 58.75M
Increased by 14.72%
Revenue Next Year
104.59M
from 67.40M
Increased by 55.18%
EPS This Year
-2.89
from -0.15
EPS Next Year
-2.09
from -2.89
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 117.7M | 151.7M | 262.9M | 97.2M | 178.3M |
| Avg | 67.4M | 104.6M | 97.1M | 88.9M | 164.1M |
| Low | 43.6M | 49.0M | 21.8M | 78.4M | 145.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 100.4% | 125.1% | 151.4% | 0.1% | 100.5% |
| Avg | 14.7% | 55.2% | -7.1% | -8.4% | 84.6% |
| Low | -25.7% | -27.3% | -79.2% | -19.3% | 63.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.62 | 1.11 | -0.07 | -1.80 | -1.58 |
| Avg | -2.89 | -2.09 | -2.28 | -1.74 | -1.53 |
| Low | -3.23 | -3.77 | -4.41 | -1.68 | -1.47 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.